{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:46:12Z","timestamp":1782823572009,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project","award":["S2021045"],"award-info":[{"award-number":["S2021045"]}]},{"name":"the Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project","award":["S2018061"],"award-info":[{"award-number":["S2018061"]}]},{"name":"Guangxi Natural Science Foundation","award":["2024GXNSFAA010160"],"award-info":[{"award-number":["2024GXNSFAA010160"]}]},{"name":"the self-financing project of the Guangxi Zhuang Autonomous Region Health Department","award":["Z20200819"],"award-info":[{"award-number":["Z20200819"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50562-7","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:42:51Z","timestamp":1777444971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary nomogram model for predicting respiratory failure of patients with idiopathic inflammatory myopathies"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaocong","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"50562_CR1","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly, C. M., Gupta, L., Fujimoto, M., Machado, P. M. & Paik, J. J. Idiopathic inflammatory myopathies: Current insights and future frontiers. Lancet Rheumatol. 6, e115\u2013e127. https:\/\/doi.org\/10.1016\/S2665-9913(23)00322-3 (2024).","journal-title":"Lancet Rheumatol."},{"key":"50562_CR2","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai, K. et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol. 75, 1528\u20131537. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598 (2018).","journal-title":"JAMA Neurol."},{"key":"50562_CR3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","volume":"61","author":"AGS Oldroyd","year":"2022","unstructured":"Oldroyd, A. G. S. et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 61, 1760\u20131768. https:\/\/doi.org\/10.1093\/rheumatology\/keac115 (2022).","journal-title":"Rheumatology (Oxford)"},{"key":"50562_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01105-9","author":"M Giannini","year":"2024","unstructured":"Giannini, M. et al. Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups. Nat. Rev. Rheumatol. https:\/\/doi.org\/10.1038\/s41584-024-01105-9 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"50562_CR5","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg, I. E. et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann. Rheum. Dis. 76, 1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"50562_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.reumae.2023.11.001","volume":"20","author":"GG Sanchez-Mendieta","year":"2024","unstructured":"Sanchez-Mendieta, G. G. et al. External validation of the 2017 ACR\/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies. Reumatol. Clin. (Engl. Ed.) 20, 142\u2013146. https:\/\/doi.org\/10.1016\/j.reumae.2023.11.001 (2024).","journal-title":"Reumatol. Clin. (Engl. Ed.)"},{"key":"50562_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003121","author":"E Zanatta","year":"2023","unstructured":"Zanatta, E. et al. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: Data from a large multicentric cohort. RMD Open https:\/\/doi.org\/10.1136\/rmdopen-2023-003121 (2023).","journal-title":"RMD Open"},{"key":"50562_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S2213-2600(24)00267-4","volume":"13","author":"S Sehgal","year":"2025","unstructured":"Sehgal, S. et al. Idiopathic inflammatory myopathies related lung disease in adults. Lancet Respir. Med. 13, 272\u2013288. https:\/\/doi.org\/10.1016\/S2213-2600(24)00267-4 (2025).","journal-title":"Lancet Respir. Med."},{"key":"50562_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge, Z. & McHugh, N. Myositis-specific autoantibodies: An important tool to support diagnosis of myositis. J. Intern. Med. 280, 8\u201323. https:\/\/doi.org\/10.1111\/joim.12451 (2016).","journal-title":"J. Intern. Med."},{"key":"50562_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"ZE Betteridge","year":"2011","unstructured":"Betteridge, Z. E., Gunawardena, H. & McHugh, N. J. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res. Ther. 13, 209. https:\/\/doi.org\/10.1186\/ar3275 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"50562_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/rheumatology\/keab492","volume":"61","author":"V Leclair","year":"2022","unstructured":"Leclair, V. et al. Autoantibody profiles delineate distinct subsets of scleromyositis. Rheumatology (Oxford) 61, 1148\u20131157. https:\/\/doi.org\/10.1093\/rheumatology\/keab492 (2022).","journal-title":"Rheumatology (Oxford)"},{"key":"50562_CR12","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/rheumatology\/keac508","volume":"62","author":"P Breillat","year":"2023","unstructured":"Breillat, P. et al. Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses. Rheumatology (Oxford) 62, 1467\u20131475. https:\/\/doi.org\/10.1093\/rheumatology\/keac508 (2023).","journal-title":"Rheumatology (Oxford)"},{"key":"50562_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.55563\/clinexprheumatol\/a4a9ln","volume":"41","author":"W Lyu","year":"2023","unstructured":"Lyu, W. et al. Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathies. Clin. Exp. Rheumatol. 41, 267\u2013274. https:\/\/doi.org\/10.55563\/clinexprheumatol\/a4a9ln (2023).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu, X., Peng, Q. & Wang, G. Anti-MDA5 antibody-positive dermatomyositis: Pathogenesis and clinical progress. Nat. Rev. Rheumatol. 20, 48\u201362. https:\/\/doi.org\/10.1038\/s41584-023-01054-9 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"50562_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107530","volume":"222","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study. Respir. Med. 222, 107530. https:\/\/doi.org\/10.1016\/j.rmed.2024.107530 (2024).","journal-title":"Respir. Med."},{"key":"50562_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10735-023-10169-y","volume":"55","author":"X Zhu","year":"2024","unstructured":"Zhu, X., Ji, J. & Han, X. Osteopontin: An essential regulatory protein in idiopathic pulmonary fibrosis. J. Mol. Histol. 55, 1\u201313. https:\/\/doi.org\/10.1007\/s10735-023-10169-y (2024).","journal-title":"J. Mol. Histol."},{"key":"50562_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04279-0","volume":"21","author":"J Ji","year":"2023","unstructured":"Ji, J. et al. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis. J. Transl. Med. 21, 640. https:\/\/doi.org\/10.1186\/s12967-023-04279-0 (2023).","journal-title":"J. Transl. Med."},{"key":"50562_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155209","volume":"135","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease. Cytokine 135, 155209. https:\/\/doi.org\/10.1016\/j.cyto.2020.155209 (2020).","journal-title":"Cytokine"},{"key":"50562_CR19","first-page":"399","volume":"33","author":"F Xiao","year":"2015","unstructured":"Xiao, F. et al. Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies. Clin. Exp. Rheumatol. 33, 399\u2013404 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1118620","volume":"14","author":"Q Nie","year":"2023","unstructured":"Nie, Q. et al. Predictive model of diabetes mellitus in patients with idiopathic inflammatory myopathies. Front. Endocrinol. (Lausanne) 14, 1118620. https:\/\/doi.org\/10.3389\/fendo.2023.1118620 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"50562_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/62836","volume":"27","author":"H Li","year":"2025","unstructured":"Li, H. et al. Mortality risk prediction in patients with antimelanoma differentiation-associated, gene 5 antibody-positive, dermatomyositis-associated interstitial lung disease: Algorithm development and validation. J. Med. Internet Res. 27, e62836. https:\/\/doi.org\/10.2196\/62836 (2025).","journal-title":"J. Med. Internet Res."},{"key":"50562_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1286973","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: The CROSS model. Front. Immunol. 15, 1286973. https:\/\/doi.org\/10.3389\/fimmu.2024.1286973 (2024).","journal-title":"Front. Immunol."},{"key":"50562_CR23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.amjmed.2005.01.062","volume":"118","author":"CM Boyd","year":"2005","unstructured":"Boyd, C. M., Xue, Q. L., Simpson, C. F., Guralnik, J. M. & Fried, L. P. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am. J. Med. 118, 1225\u20131231. https:\/\/doi.org\/10.1016\/j.amjmed.2005.01.062 (2005).","journal-title":"Am. J. Med."},{"key":"50562_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022","author":"M Humbert","year":"2023","unstructured":"Humbert, M. et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00879-2022 (2023).","journal-title":"Eur. Respir. J."},{"key":"50562_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.02.045","author":"SA Guler","year":"2024","unstructured":"Guler, S. A. et al. Interdisciplinary diagnosis and management of patients with interstitial lung disease and connective tissue disease. Chest https:\/\/doi.org\/10.1016\/j.chest.2024.02.045 (2024).","journal-title":"Chest"},{"key":"50562_CR26","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider, L. G. et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res. (Hoboken) 63, S118\u2013S157. https:\/\/doi.org\/10.1002\/acr.20532 (2011).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"50562_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard, H. R. et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group report. Am. J. Respir. Crit. Care Med. 194, 265\u2013275. https:\/\/doi.org\/10.1164\/rccm.201604-0801CI (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"50562_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.55563\/clinexprheumatol\/kgpnbq","volume":"42","author":"M Fornaro","year":"2024","unstructured":"Fornaro, M. et al. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis. Clin. Exp. Rheumatol. 42, 288\u2013294. https:\/\/doi.org\/10.55563\/clinexprheumatol\/kgpnbq (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03100-z","volume":"25","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody. Arthritis Res. Ther. 25, 127. https:\/\/doi.org\/10.1186\/s13075-023-03100-z (2023).","journal-title":"Arthritis Res. Ther."},{"key":"50562_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.860798","volume":"9","author":"ZM Ouyang","year":"2022","unstructured":"Ouyang, Z. M. et al. A matrix prediction model for the 6-month mortality risk in patients with Anti-melanoma differentiation-associated protein-5-positive dermatomyositis. Front. Med. (Lausanne) 9, 860798. https:\/\/doi.org\/10.3389\/fmed.2022.860798 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"50562_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02843-w","volume":"25","author":"W He","year":"2024","unstructured":"He, W. et al. Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: A multi-center retrospective study. Respir. Res. 25, 252. https:\/\/doi.org\/10.1186\/s12931-024-02843-w (2024).","journal-title":"Respir. Res."},{"key":"50562_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845988","volume":"13","author":"Y Zuo","year":"2022","unstructured":"Zuo, Y. et al. Different multivariable risk factors for rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis and anti-synthetase syndrome. Front. Immunol. 13, 845988. https:\/\/doi.org\/10.3389\/fimmu.2022.845988 (2022).","journal-title":"Front. Immunol."},{"key":"50562_CR33","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s10067-024-06948-x","volume":"43","author":"J Liang","year":"2024","unstructured":"Liang, J. et al. An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients. Clin. Rheumatol. 43, 1959\u20131969. https:\/\/doi.org\/10.1007\/s10067-024-06948-x (2024).","journal-title":"Clin. Rheumatol."},{"key":"50562_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.55563\/clinexprheumatol\/8ievtq","volume":"41","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction. Clin. Exp. Rheumatol. 41, 330\u2013339. https:\/\/doi.org\/10.55563\/clinexprheumatol\/8ievtq (2023).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16382-1","volume":"12","author":"S Shi","year":"2022","unstructured":"Shi, S. et al. Development of a scoring system with multidimensional markers for fibrosing interstitial lung disease. Sci. Rep. 12, 14217. https:\/\/doi.org\/10.1038\/s41598-022-16382-1 (2022).","journal-title":"Sci. Rep."},{"key":"50562_CR36","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/IJGM.S310917","volume":"14","author":"Y Bao","year":"2021","unstructured":"Bao, Y. et al. Correlation between serum tumor marker levels and connective tissue disease-related interstitial lung disease. Int. J. Gen. Med. 14, 2553\u20132560. https:\/\/doi.org\/10.2147\/IJGM.S310917 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"50562_CR37","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1093\/rheumatology\/keaa819","volume":"60","author":"D Zhu","year":"2021","unstructured":"Zhu, D. et al. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis. Rheumatology (Oxford) 60, 3896\u20133903. https:\/\/doi.org\/10.1093\/rheumatology\/keaa819 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"50562_CR38","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10067-022-06089-z","volume":"41","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis. Clin. Rheumatol. 41, 1731\u20131739. https:\/\/doi.org\/10.1007\/s10067-022-06089-z (2022).","journal-title":"Clin. Rheumatol."},{"key":"50562_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/2050312118781895","volume":"6","author":"CH Lim","year":"2018","unstructured":"Lim, C. H. et al. The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis\/polymyositis patients: A retrospective study. SAGE Open Med. 6, 2050312118781895. https:\/\/doi.org\/10.1177\/2050312118781895 (2018).","journal-title":"SAGE Open Med."},{"key":"50562_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12016-022-08922-4","volume":"63","author":"M Marzecka","year":"2022","unstructured":"Marzecka, M., Niemczyk, A. & Rudnicka, L. Autoantibody markers of increased risk of malignancy in patients with dermatomyositis. Clin. Rev. Allergy Immunol. 63, 289\u2013296. https:\/\/doi.org\/10.1007\/s12016-022-08922-4 (2022).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"50562_CR41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22978","volume":"14","author":"H Marasandra Ramesh","year":"2022","unstructured":"Marasandra Ramesh, H. et al. The role of myositis-specific autoantibodies in the dermatomyositis spectrum. Cureus 14, e22978. https:\/\/doi.org\/10.7759\/cureus.22978 (2022).","journal-title":"Cureus"},{"key":"50562_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","volume":"19","author":"AGS Oldroyd","year":"2023","unstructured":"Oldroyd, A. G. S. et al. International guideline for idiopathic inflammatory myopathy-associated cancer screening: An International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat. Rev. Rheumatol. 19, 805\u2013817. https:\/\/doi.org\/10.1038\/s41584-023-01045-w (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"50562_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.55563\/clinexprheumatol\/1vz1p2","volume":"42","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Predictors of mortality for dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 and optimal treatment. Clin. Exp. Rheumatol. 42, 246\u2013252. https:\/\/doi.org\/10.55563\/clinexprheumatol\/1vz1p2 (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.882","volume":"11","author":"L Lian","year":"2023","unstructured":"Lian, L., Tong, J. J. & Xu, S. Q. Clinical features and prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients. Immun. Inflamm. Dis. 11, e882. https:\/\/doi.org\/10.1002\/iid3.882 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"50562_CR45","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/joim.13607","volume":"293","author":"Q Jin","year":"2023","unstructured":"Jin, Q. et al. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. J. Intern. Med. 293, 494\u2013507. https:\/\/doi.org\/10.1111\/joim.13607 (2023).","journal-title":"J. Intern. Med."},{"key":"50562_CR46","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1093\/rheumatology\/keaa266","volume":"59","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease. Rheumatology (Oxford) 59, 3886\u20133891. https:\/\/doi.org\/10.1093\/rheumatology\/keaa266 (2020).","journal-title":"Rheumatology (Oxford)"},{"key":"50562_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.41566","volume":"73","author":"T Gono","year":"2021","unstructured":"Gono, T. et al. Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol. 73, 677\u2013686. https:\/\/doi.org\/10.1002\/art.41566 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"50562_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34145-4","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye, Y. et al. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. Nat. Commun. 13, 6458. https:\/\/doi.org\/10.1038\/s41467-022-34145-4 (2022).","journal-title":"Nat. Commun."},{"key":"50562_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/art.41075","volume":"72","author":"AS Galindo-Feria","year":"2020","unstructured":"Galindo-Feria, A. S. et al. Proinflammatory histidyl-transfer RNA synthetase-specific CD4+ T cells in the blood and lungs of patients with idiopathic inflammatory myopathies. Arthritis Rheumatol. 72, 179\u2013191. https:\/\/doi.org\/10.1002\/art.41075 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"50562_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1905-z","volume":"21","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis. Arthritis Res. Ther. 21, 131. https:\/\/doi.org\/10.1186\/s13075-019-1905-z (2019).","journal-title":"Arthritis Res. Ther."},{"key":"50562_CR51","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3892\/mmr.2017.6693","volume":"16","author":"X Shu","year":"2017","unstructured":"Shu, X. et al. Potential role of autophagy in T\u2011cell survival in polymyositis and dermatomyositis. Mol. Med. Rep. 16, 1180\u20131188. https:\/\/doi.org\/10.3892\/mmr.2017.6693 (2017).","journal-title":"Mol. Med. Rep."},{"key":"50562_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge, Z. et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J. Autoimmun. 101, 48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001 (2019).","journal-title":"J. Autoimmun."},{"key":"50562_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/acr2.11247","volume":"3","author":"J Albayda","year":"2021","unstructured":"Albayda, J. et al. A North American cohort of Anti-SAE dermatomyositis: Clinical phenotype, testing, and review of cases. ACR Open Rheumatol. 3, 287\u2013294. https:\/\/doi.org\/10.1002\/acr2.11247 (2021).","journal-title":"ACR Open Rheumatol."},{"key":"50562_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.55563\/clinexprheumatol\/110r0p","volume":"42","author":"M Fornaro","year":"2024","unstructured":"Fornaro, M. et al. Anti-SAE dermatomyositis: Clinical and histologic characteristics from a monocentric Italian cohort. Clin. Exp. Rheumatol. 42, 295\u2013301. https:\/\/doi.org\/10.55563\/clinexprheumatol\/110r0p (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"50562_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030725","author":"HC Tsai","year":"2024","unstructured":"Tsai, H. C. et al. Antibodies against small ubiquitin-like modifier activating enzyme may be a protective factor from rapid progressive Interstitial Lung Disease in patients bearing antibodies against Melanoma Differentiation Associated Gene 5. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm13030725 (2024).","journal-title":"J. Clin. Med."},{"key":"50562_CR56","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s10067-019-04562-w","volume":"38","author":"E Jia","year":"2019","unstructured":"Jia, E. et al. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: A case report and literature review. Clin. Rheumatol. 38, 2189\u20132193. https:\/\/doi.org\/10.1007\/s10067-019-04562-w (2019).","journal-title":"Clin. Rheumatol."},{"key":"50562_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri2460","volume":"9","author":"H Cantor","year":"2009","unstructured":"Cantor, H. & Shinohara, M. L. Regulation of T-helper-cell lineage development by osteopontin: The inside story. Nat. Rev. Immunol. 9, 137\u2013141. https:\/\/doi.org\/10.1038\/nri2460 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"50562_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071969","author":"R Chunder","year":"2023","unstructured":"Chunder, R., Schropp, V., Marzin, M., Amor, S. & Kuerten, S. A dual role of Osteopontin in modifying B Cell responses. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines11071969 (2023).","journal-title":"Biomedicines"},{"key":"50562_CR59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02441-2018","author":"C Morse","year":"2019","unstructured":"Morse, C. et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.02441-2018 (2019).","journal-title":"Eur. Respir. J."},{"key":"50562_CR60","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1111\/febs.15669","volume":"288","author":"J Hou","year":"2021","unstructured":"Hou, J. et al. Alveolar epithelial cell-derived Sonic hedgehog promotes pulmonary fibrosis through OPN-dependent alternative macrophage activation. FEBS J. 288, 3530\u20133546. https:\/\/doi.org\/10.1111\/febs.15669 (2021).","journal-title":"FEBS J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50562-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:09:32Z","timestamp":1782821372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50562-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50562"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50562-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by The Ethics Committee of the People\u2019s Hospital of Guangxi Zhuang Autonomous Region (ethics approval number:KY-SY-2021-9).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication and grant the publisher an exclusive license for full copyright.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"19858"}}